Illumina today announced that its startup accelerator has secured $40 million from Viking Global Investors to fund promising genomic firms.
Accelerator graduates that raise between $1 million and $5 million in new capital will receive additional dollar-for-dollar match funding from Illumina Accelerator Boost Capital.
Read more at GenomeWeb
